Cuba exposure profile · MRK ·
Health Care
Merck & (MRK): Cuba Exposure Check
Independent audit of Merck & Co.'s exposure to Cuba — OFAC SDN matches, Helms-Burton Title III risk, SEC filings, and the Cuban Insights news corpus.
OFAC Cuba SDN matches
No entry on the OFAC Cuba SDN list contains
Merck &
as of the most recent OFAC scrape. Always re-verify with
OFAC Sanctions Search
before transacting.
SEC filings disclosing Cuba items
We searched Merck &'s SEC filings (10-K,
10-Q, 8-K, 20-F, 6-K) for the past two years and found no
mention of Cuba, CACR, Helms-Burton, GAESA, or Havana. This is
consistent with no material disclosed exposure. The full SEC
full-text search is here:
EDGAR full-text search for Merck &
.
Federal Register & news corpus mentions
No Federal Register notice or analyzed news article in our
corpus references Merck & in a
Cuba context. Search the live
sanctions tracker
or the
daily briefing index
for ad-hoc context.
Cuban Insights analyst note
Merck supplies certain pharmaceuticals to Cuba under the §515.559 medicine general license. Cuban biotech sector (BioCubaFarma) is a notable counterparty for joint research and licensing inquiries where authorized.
Relevant OFAC general licenses (CACR §515.560–.578): CACR §515.559 — browse the full GL directory.
Methodology.
This page combines four signals: (1) a hand-curated map of S&P 500
Cuba exposure maintained by Cuban Insights analysts;
(2) fuzzy substring matching against every Cuba-program OFAC SDN
designation and the State Department Cuba Restricted List (refreshed
twice daily); (3) the SEC EDGAR full-text search across the company's
10-K, 10-Q, 8-K, 20-F, and 6-K filings for the past 24 months — including
Helms-Burton Title III trafficking-claim disclosures; (4) a scan of our
own analyzed-news corpus and US Federal Register notices. Last refreshed
2026-04-21. This is not legal or compliance advice;
always verify with primary sources and qualified sanctions counsel
before transacting.
Frequently asked questions
Is Merck & (MRK) sanctioned by OFAC?
As of April 2026, Merck & (MRK) is not listed on the OFAC CUBA-program SDN list. No direct or subsidiary entity match was found in our scan against the live US Treasury SDN feed. Note that the State Department's Cuba Restricted List and Cuba Prohibited Accommodations List apply separately and should be checked alongside the SDN. Always re-verify against the official OFAC Sanctions Search before relying on this for a compliance decision.
Does Merck & have Cuba revenue exposure?
Merck & has indirect Cuba exposure via subsidiaries or counterparties. Merck supplies certain pharmaceuticals to Cuba under the §515.559 medicine general license. Cuban biotech sector (BioCubaFarma) is a notable counterparty for joint research and licensing inquiries whe
Has Merck & disclosed Cuba in its SEC filings?
No recent SEC filings by Merck & (MRK) contain Cuba, Helms-Burton, CACR, or Havana references in our EDGAR search across 10-K, 10-Q, 8-K, 20-F, and 6-K forms over the last 24 months. Use SEC EDGAR's full-text search to verify.
Useful tools
- Look up another public company's Cuba exposure
- SEC EDGAR Cuba / Helms-Burton / impairment search — pre-canned full-text search across S&P 500 10-K and 20-F filings
- OFAC Cuba sanctions checker — fuzzy SDN search by name or ID
- OFAC Cuba general licenses lookup (CACR §515.560–.578)
- Browse all active OFAC Cuba SDN designations
- Plain-English explainer: OFAC Cuba sanctions